Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)

Targeting of Rac GTPases blocks the spread of intact human breast cancer

(2015) Elad Katz et al.   Oncotarget

p16 Stimulates CDC42-Dependent Migration of Hepatocellular Carcinoma Cells

(2013) Ya-Wen Chen et al.   PLoS One

Nuclear expression of Rac1 in cervical premalignant lesions and cervical cancer cells

(2012) Miguel A Mendoza-Catalán et al.   BMC CANCER

The role of Rac1 in the regulation of NF-kB activity, cell proliferation, and cell migration in non-small cell lung carcinoma

(2012) Adam Gastonguay et al.   CANCER BIOLOGY & THERAPY

Neuroendocrine differentiation in head and neck squamous cell carcinoma

(2012) V H Schartinger et al.   JOURNAL OF LARYNGOLOGY AND OTOLOGY

Predicting Recurrence After Radiotherapy in Head and Neck Cancer

(2012) Adrian C. Begg   SEMINARS IN RADIATION ONCOLOGY

Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus–associated head and neck squamous cell carcinoma?

(2011) Jaiyeola Thomas et al.   Annals of Diagnostic Pathology

Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells

(2011) Min-Soo Koh et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck

(2011) Adrian R. Levy et al.   CURRENT MEDICAL RESEARCH AND OPINION

Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts

(2011) József Dudás et al.   EXPERIMENTAL CELL RESEARCH

Radioresistant head and neck squamous cell carcinoma cells: Intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets

(2011) Sergej Skvortsov et al.   RADIOTHERAPY AND ONCOLOGY

The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies

(2010) J. A. Langendijk et al.   ANNALS OF ONCOLOGY

Optimal treatment for recurrent/metastatic head and neck cancer

(2010) J. B. Vermorken et al.   ANNALS OF ONCOLOGY

Protein biomarker discovery for head and neck cancer

(2010) Tieneke B.M. Schaaij-Visser et al.   Journal of Proteomics

Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer

(2010) Nikolaos Tselis et al.   RADIOTHERAPY AND ONCOLOGY

Targeted therapies in squamous cell carcinoma of the head and neck

(2009) Kathryn A. Gold et al.   CANCER

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma

(2009) Q. Ma et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma

(2009) Maarten Lambrecht et al.   RADIOTHERAPY AND ONCOLOGY

TGFβ in Cancer

(2008) Joan Massagué   CELL

Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division

(2008) David Michaelson et al.   JOURNAL OF CELL BIOLOGY

Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

(2008) Maura L. Gillison et al.   JNCI-Journal of the National Cancer Institute

Recent Advances in Head and Neck Cancer

(2008) Robert I. Haddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regulation of Membrane Trafficking, Cytoskeleton Dynamics, and Cell Polarity by ROP/RAC GTPases

(2008) S. Yalovsky et al.   PLANT PHYSIOLOGY

Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells

(2008) Ira Skvortsova et al.   PROTEOMICS

Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells

(2007) Fumiko Iwashima et al.   ENDOCRINOLOGY